Tenacore

BD’s Alaris pump hit with another recall

(Image courtesy of BD)

A medical supply company is recalling BD (NYSE:BDX) Alaris infusion pumps — the third such recall for the pumps in the past few months, according to the FDA.

North Carolina-based Avante Health Solutions issued the Alaris pump recall March 24, 2021, because the bezel repair posts may crack or separate, leading to the inaccurate delivery of fluids to patients. The separation of one or more bezel repair posts could result in the free flow of fluids to patients, over- or under-delivery of fluids, interruption of fluid delivery, device leaks, device component burning or smoking and/or power supply failure or malfunction.

Get the full story on our sister site, Drug Delivery Business News.

Pump problem prompts another Alaris recall

Days after classifying one recall for the Alaris infusion pump, the FDA has issued another Class I recall for the device.

On Friday of last week, the FDA issued a Class I recall — the most serious kind — for the BD (NYSE:BDX) Alaris because there is a risk of the keypad lifting up due to fluid entry, an issue that could result in keys that become unresponsive or stuck. BD initiated that recall on March 3, 2021.

Get the full story at our sister site, Drug Delivery Business News.